Skip to main content
DHR
NYSE Life Sciences

Danaher Beats Q2 Estimates, Raises Full-Year EPS Guidance to $8.45-$8.60

Tom Rudovsky · Reported by Reuters
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$184
Mkt Cap
$142.34B
52W Low
$160.93
52W High
$242.8
52W Position info
14% above low
Off High info
24% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

DHR is trading near its 52-week low of $160.93 (14% above the low).

Summary

Danaher delivered a strong Q2 beat with revenue of $6.27B and adjusted EPS of $1.94, topping consensus by $170M and $0.11 respectively. The Life Sciences segment posted its best quarter in years, while bioprocessing orders grew mid-teens despite revenue timing headwinds. Management raised full-year adjusted EPS guidance to $8.45-$8.60 and expects 3%-4% core revenue growth, reflecting confidence from the earlier-than-expected Masimo acquisition close. This follows the 10-Q filed yesterday and adds concrete quarterly numbers and raised annual targets. The stock trades at 23x forward earnings with a median analyst target of $237.50, suggesting room to run if execution continues.

At the time of this announcement, DHR was trading at $184.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $142.3B. The 52-week trading range was $160.93 to $242.80. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

DHR - Latest Insights

DHR
Nov 02, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $237.50
Real-time Price: $236.77 info
Change: -$0.7287 (-0.31%) info
Market Cap: $166.111B info
DHR
Oct 21, 2026, 11:24 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $230.83
Real-time Price: $236.77 info
Change: +$5.94 (+3%) info
Market Cap: $166.111B info
DHR
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $221.00
Real-time Price: $236.77 info
Change: +$15.77 (+7%) info
Market Cap: $166.111B info
DHR
Oct 20, 2026, 5:43 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $221.20
Real-time Price: $236.77 info
Change: +$15.57 (+7%) info
Market Cap: $166.111B info
DHR
Oct 20, 2026, 5:40 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $221.20
Real-time Price: $236.77 info
Change: +$15.57 (+7%) info
Market Cap: $166.111B info